Wintrust Investments LLC acquired a new stake in Colgate-Palmolive (NYSE:CL – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 362 shares of the company’s stock, valued at approximately $33,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of CL. State Street Corp boosted its position in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the period. Geode Capital Management LLC raised its stake in Colgate-Palmolive by 2.8% during the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after purchasing an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Colgate-Palmolive by 6.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock worth $988,997,000 after acquiring an additional 557,492 shares during the last quarter. Amundi boosted its holdings in Colgate-Palmolive by 12.8% in the fourth quarter. Amundi now owns 9,200,144 shares of the company’s stock worth $806,015,000 after purchasing an additional 1,040,604 shares in the last quarter. Finally, Barclays PLC boosted its holdings in Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the period. 80.41% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on CL. TD Cowen cut their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Morgan Stanley dropped their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday, March 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $101.61.
Colgate-Palmolive Stock Down 0.4 %
Shares of CL stock opened at $90.41 on Friday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The firm’s 50-day moving average is $89.03 and its 200-day moving average is $94.93. The stock has a market cap of $73.37 billion, a price-to-earnings ratio of 25.69, a PEG ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the company posted $0.87 EPS. Sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How to Calculate Options Profits
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.